The COCOON trial: wrapping potent EGFR therapy in proactive supportive care
Kushal Kriplani, Won Jin Jeon, Jeremy Cetnar, Chetan Vakkalagadda, Rajat Thawani · 2026
Read The COCOON trial: wrapping potent EGFR therapy in proactive supportive care by Kushal Kriplani, Won Jin Jeon, Jeremy Cetnar, Chetan Vakkalagadda, Rajat Thawani (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13266859.txt.
Description
Kushal Kriplani and co-authors comment in 2026 on the COCOON trial, which paired a strong lung cancer drug combination with preventive skin care. The drugs amivantamab and lazertinib beat an older standard for EGFR-mutant cancer, yet they cause rash and nail inflammation in most patients. The trial asked whether structured skin care started early could cut that burden.
Two hundred one patients were assigned to enhanced skin care or usual care. The enhanced plan combined an oral antibiotic, scalp treatment, antiseptic wash, and daily moisturizer. Moderate or worse skin problems by week twelve were far less common with enhanced care, especially on the face, body, and scalp. Proactive skin care may help patients stay on an effective but harsh regimen.
Catalog record
| CREATOR | Kushal Kriplani, Won Jin Jeon, Jeremy Cetnar, Chetan Vakkalagadda, Rajat Thawani |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |